Clinical usefulness of geriatric assessment in elderly patients with unresectable hepatocellular carcinoma receiving sorafenib or lenvatinib therapy.
Cancer reports (Hoboken, N.J.)（2022）
摘要
The mG8 score may contribute to making a decision when considering either sorafenib or lenvatinib as a treatment option for u-HCC in elderly patients.
更多查看译文
关键词
1,Geriatric 8 score,hepatocellular carcinoma 2,lenvatinib 4,sorafenib 3
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要